Agilent Technologies (A) Shares are Down -1.29%

Agilent Technologies (A) has risen sharply, recording gains of 4.42% in the past 4 weeks. However, the stock has corrected -1.29% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 1.89% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

Agilent Technologies (NYSE:A): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $47.10 and $47.10 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $47.54. The buying momentum continued till the end and the stock did not give up its gains. It closed at $47.49, notching a gain of 1.41% for the day. The total traded volume was 1,250,805 . The stock had closed at $46.83 on the previous day.

The stock has recorded a 20-day Moving Average of 1.45% and the 50-Day Moving Average is 3.78%. Agilent Technologies, Inc. is up 14.93% in the last 3-month period. Year-to-Date the stock performance stands at 14.21%.

Agilent Technologies (A) has been rated by 7 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $55 and the lowest price target forecast is $45. The average forecast of all the analysts is $49.14 and the expected standard deviation is $3.18.


Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.